Loncar China BioPharma ETF (CHNA) 是一家上市公司 属于 金融服务 板块，经营于 资产管理 行业.
CHNA 拥有 IPO日期为 2018-08-15, 在 NASDAQ Global Market.
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
